- Home
- BLX vs CLDX Comparison
BLX vs CLDX Comparison
Compare BLX & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLX
- CLDX
- Stock Information
- Founded
- BLX 1977
- CLDX N/A
- Country
- BLX Panama
- CLDX United States
- Employees
- BLX N/A
- CLDX N/A
- Industry
- BLX Commercial Banks
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- BLX Finance
- CLDX Health Care
- Exchange
- BLX Nasdaq
- CLDX Nasdaq
- Market Cap
- BLX 1.5B
- CLDX 1.3B
- IPO Year
- BLX N/A
- CLDX 2008
- Fundamental
- Price
- BLX $42.38
- CLDX $22.77
- Analyst Decision
- BLX
- CLDX Buy
- Analyst Count
- BLX 0
- CLDX 9
- Target Price
- BLX N/A
- CLDX $50.00
- AVG Volume (30 Days)
- BLX 130.0K
- CLDX 1.2M
- Earning Date
- BLX 07-22-2025
- CLDX 08-07-2025
- Dividend Yield
- BLX 5.91%
- CLDX N/A
- EPS Growth
- BLX 13.55
- CLDX N/A
- EPS
- BLX 5.60
- CLDX N/A
- Revenue
- BLX $289,499,000.00
- CLDX $7,559,000.00
- Revenue This Year
- BLX $13.23
- CLDX N/A
- Revenue Next Year
- BLX $7.79
- CLDX N/A
- P/E Ratio
- BLX $7.55
- CLDX N/A
- Revenue Growth
- BLX 13.37
- CLDX 24.49
- 52 Week Low
- BLX $27.37
- CLDX $14.40
- 52 Week High
- BLX $42.88
- CLDX $47.00
- Technical
- Relative Strength Index (RSI)
- BLX 61.17
- CLDX 62.80
- Support Level
- BLX $40.14
- CLDX $20.76
- Resistance Level
- BLX $42.62
- CLDX $22.47
- Average True Range (ATR)
- BLX 0.70
- CLDX 1.22
- MACD
- BLX 0.09
- CLDX 0.17
- Stochastic Oscillator
- BLX 84.88
- CLDX 87.88
About BLX Banco Latinoamericano de Comercio Exterior S.A.
Banco Latinoamericano de Comercio Exterior SA provides financial solutions to financial institutions, companies, and investors doing business in Latin America, supporting trade and regional integration. The Bank provides foreign trade solutions to a select client base of American financial institutions and corporations and has developed a network of correspondent banking institutions with access to the international capital markets. It has two business segments: the Commercial Business Segment and the Treasury Business Segment. The majority of its revenue is generated from the Commercial Business segment.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.